RT Journal Article
SR Electronic
T1 Impact of a Wearable Activity Tracker on Disease Flares in Spondyloarthritis: A Randomized Controlled Trial
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 1109
OP 1116
DO 10.3899/jrheum.220140
VO 49
IS 10
A1 Guillaume Labat
A1 Meggy Hayotte
A1 Laurent Bailly
A1 Roxane Fabre
A1 Olivier Brocq
A1 Pauline Gerus
A1 Véronique Breuil
A1 Manuella Fournier-Mehouas
A1 Raphaël Zory
A1 Fabienne D’Arripe-Longueville
A1 Christian H. Roux
YR 2022
UL http://www.jrheum.org/content/49/10/1109.abstract
AB Objective To evaluate the impact of a wearable activity tracker used to encourage physical activity, on disease flares in patients with spondyloarthritis (SpA).Methods This randomized controlled trial involved randomizing 108 patients with SpA into tracker and nontracker groups. The participants were then subjected to assessments of disease activity, performance (6-minute walk test), and quality of life (QOL; 36-item Short Form Health Survey) at the 12th, 24th, and 36th week. The primary outcome was the change in the frequency of flare episodes (categorized as no flare, flare in ≤ 3 days, and flare in > 3 days) between baseline and 12 weeks.Results The results of the study showed that at the 12th week, the mean change (∆) of the number of flares improved in both groups: −0.32 (95% CI −0.66 to 0.02) and −0.38 (95% CI −0.68 to −0.09) in the tracker and nontracker group, respectively. However, the between-group differences were insignificant (P = 0.87). Performance scores improved in both groups at the 12th, 24th, and 36th week (all P < 0.01). The different dimensions of QOL also improved at the 12th week (P < 0.01). Conversely, moderate flares (P < 0.01) and performance (P < 0.01) improved over time; however, the influence over time of a wearable activity tracker was not significant (P = 0.29 and P = 0.66, respectively).Conclusion The use of a wearable activity tracker did not affect the number of flares, performance, or QOL of patients with SpA. Nevertheless, this study confirmed the benefits of physical activity on flares, disease activity, QOL, and physical performance in patients with SpA. (Move Your Spondyl “Better Live Its Rheumatism With the Physical Activity”; ClinicalTrials.gov: NCT03458026)